Dental Microsurgery Market Latest Growth & Future Trends

The global dental microsurgery market size is expected to reach USD 339.6 million by 2026, according to a new report by Grand View Research, Inc. It is anticipated to expand at a 4.3% during the forecast period. Factors such as high prevalence of dental disorders, especially among elderly and increasing need for high precision surgical and optical/visualization equipment are anticipated to drive the growth.

Endodontic procedure segment is projected to register the fastest CAGR over the forecast period. These procedures heavily rely on microsurgery and related equipment. Modern endodontic procedures are associated with both dental disorder treatment and aesthetic dentistry. Microsurgical equipment are compact yet durable and precise to reduce the scarring and provide a cosmetically as well as functionally superior results. Visual/optical instrumentation and lighting are the crucial elements of dental microsurgery. Surgical microscopes are an integral part of endodontic practice and are used to increase visibility, reduce soft tissue trauma, and ultimately to improve the end results.

Rising population coupled with high prevalence of dental disorders in developing economies is anticipated to create opportunity for the market players to introduce innovative surgical techniques. Among every 100,000 Indians, approximately 31,489 males and 33,926 females suffered from dental caries in 2018. In addition, growing dental tourism in Asia, especially in Thailand is expected to drive the growth of the dental microsurgery market over the forecast period.

Factors such as significant cost of microsurgery and lack of skilled endodontists are expected to hamper the market growth. Nonetheless, growing spending power coupled with willingness to spend more on aesthetic dental surgeries is expected to boost the expansion of the market. Moreover, rising number of dental practitioners is anticipated to bode well for the overall market growth in the forthcoming years.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/dental-microsurgery-market

Dental Microsurgery Market Report Highlights

• Optical/viewing instruments held the maximum share of the dental microsurgery market in 2018, driven by the high preference for the product by dentists due to its various benefits
• The others segment is expected to register the fastest CAGR over the forecast period owing to increasing use of dental syringes and aspirating devices among others due to their advantages
• Endodontic procedures segment is projected to register the fastest CAGR over the forecast period owing to growing awareness coupled with importance for both surgical and non-surgical endodontic procedures and prominent use of microsurgery in endodontic procedures
• Asia Pacific is expected to witness the fastest CAGR in near future owing to the factors such as growing awareness regarding dental hygiene along with rising geriatric population, medical tourism, and government initiatives for optimal oral health
• Some of the key market players are Carl Zeiss Meditech Group; Global Surgical Corporation; Albert Waeschle Ltd.; Synovis Micro Companies Alliance, Inc.; and Hu-Friedy

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

Smart Healthcare Market Growth & Trends

The global smart healthcare market size is anticipated to reach USD 528.9 billion by 2027, registering a CAGR of 16.2%, as per the new report by Grand View Research, Inc. The COVID-19(coronavirus) pandemic is likely to boost the market growth as these solutions help healthcare professionals to connect effectively with their patients and offer quality treatment. Owing to social distancing, remote patient monitoring, and virtual healthcare delivery is gaining momentum. For instance, U.K. has introduced free virtual consultation during the coronavirus crisis. In April 2020, doctorinthehouse.net, a not-for-profit online healthcare service in U.K.launched a platform in collaboration with volunteers amongst doctors, pharmacists, specialist nurses aiming to schedule 25,000 online appointments and supply 100,000 online assessments over 200 at-home clinicians. Such initiatives are expected to drive the market ahead.

Operating costs are mainly governed by production costs, inventory storage costs, manufacturing overhead costs, wages, energy costs, and logistical costs. Poor inventory control is a major issue faced by companies that leads to substantial operating losses. There is an increasing demand for RFID kanban systems to control their inventory costs. RFID kanban systems owing to associated benefits such as reduction in manpower, higher efficiency, and cost effectiveness is anticipated drive traction over the forecast period.

Technological advancements are rapidly transforming the market for smart healthcare. Some of the major market players such as IBM, Cisco, Given Imaging, Inc., Olympus Corporation, Logi-Tag, Brooks Automation, Stanley Innerspace, GE Healthcare, and others account for a substantial market share, owing to their extensive product offerings.Key players are focusing on expanding their current portfolio such as in March 2020, Siemens Healthineers launched Teamplay digital health platform. It is aimed to enable digital healthcare transformation and eases quick access to clinical and operational solutions. Also, in June 2019, Intel introduced Network And Custom Logic Group it is a broad portfolio of products for Artificial Intelligence (AI) and 5G cloud. This is aimed to broaden the horizons of healthcare application.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/smart-healthcare-market

Smart Healthcare Market Report Highlights

• mHealth held the dominant share due to the growing usage of internet, penetration of smartphones, and the increased adoption of mHealth technologies by healthcare professionals and patients
• Telemedicine is expected to be the second fastest-growing segment from 2020 to 2027. Growing prevalence of chronic conditions, rising demand for self healthcare, and outbreak of COVID 19 pandemic are the key factors driving the growth
• Smart Pills demonstrated promising growth during the forecast period owing to technological development including miniaturization of integrated circuits, an increase in focus on patient convenience, and high demand for minimally invasive procedures
• Siemens Medical Solutions; IBM; AT&T Inc.; Apple Inc.; GE Healthcare; and Cisco are some of the major market participants due to their regional presence and product offerings
• Companies are adopting innovative strategies to attain a competitive advantage. Product development, partnerships, strategic collaborations, mergers and acquisitions, and regional expansion are a few of them

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

Internet of Things in Healthcare Market Size, Share & Trends Analysis Report 2025

The global IoT in healthcare market size is projected to reach USD 534.3 billion by 2025 expanding at a CAGR 19.9% over the forecast period, according to a new report by Grand View Research, Inc. Rise in investments for the implementation of IoT solutions in healthcare sector is one of the key factors driving the market. Increasing penetration of connected devices in various healthcare institutes and adoption of IoT systems and software solutions in healthcare operational activities are also among the key factors augmenting the market growth.

Growing preference for real-time data monitoring among the healthcare practitioners to manage chronic diseases is expected to propel the demand for IoT network in healthcare institutions. Combinations of remote monitoring, mobile platforms, and analytics have cut the rate of readmissions of patients suffering from congestive heart failure, diabetes, and blood pressure. Furthermore, advancements in communication technologies, such as real-time data transmission, has positively impacted the patients in manage chronic diseases and medication dosage, which has further fostered the market growth.

For instance, connected wheelchairs allow people with disabilities to communicate health alerts to care teams and engage with care providers. Growing number of IoT platform installations for better and early diagnosis and disease tracking is also contributing to the market development. Furthermore, rising demand for digital technologies for managing diseases, such as insomnia, diabetes, autism, heart disease, and asthma, is also poised to spur the market growth.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/internet-of-things-iot-healthcare-market

IoT in Healthcare Market Report Highlights

• In 2018, services held the largest revenue share owing to the high demand for improved decision-making in real-time and uninterrupted data flow between devices and people to uplift the efficiency of medical systems
• Hospitals and clinics held the largest revenue share in 2018 due to increased investments by hospitals to encourage the usage of digital technologies
• North America is expected to be the largest market owing to growing adoption of healthcare IT solutions and availability of sophisticated infrastructure in the region
• Asia pacific expected to witness the fastest CAGR over the forecast period owing to growing investments by the pharmaceuticals & medical devices companies and increasing adoption of advanced technologies
• Key companies operating in this market include Koninklijke Philips N.V., Drägerwerk AG & Co. KGaA, Biotronik, and Boston Scientific

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

Therapeutic Respiratory Devices Market Size, Share, Latest Trends, Industry Growth And Demand

The global therapeutic respiratory devices market is anticipated to reach USD 18.0 billion by 2025, according to a new report by Grand View Research, Inc. Growing geriatric population base, rising prevalence of respiratory diseases, and rapid technological advancements are the key factors that are driving the market growth.

The therapeutic respiratory devices market growth is anticipated to increase due to rapid technological advancements in the market.Now-a-days, the respiratory monitoring devices utilize software applications for the collection and analysis of data from ventilators equipped across the health system. The tools in the software application allow improvised patient monitoring by the measurement of parameters such as process and clinical variation in the ventilator therapy.

Furthermore, waveform capnography is a useful technical advancement in monitoring the carbon dioxide levels. The launch of new products such as automated and stand-alone pressure controller for mechanical ventilators boost the growth of therapeutic respiratory devices market. These pressure controllers enable reduction in the risk of tracheal injuries and Ventilator Associated Pneumonia (VAP). For instance, in May 2015, Fischer and Paykel launched its new product AIRVO Nasal High Flow System, which provides comfort and stability for patients. It has soft contoured cheek pads and prongs, uninterrupted power supply transport, and tube technology with two way spiral design. The company also offers humidifier with integrated flow generator, which delivers high flows of air mixture to spontaneously breathing patient. Such factors are bolstering the growth of the market.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/therapeutic-respiratory-devices-market

Further Key Findings From the Study Suggest:

• Positive airway pressure devices accounted for the largest share in 2016 owing to technological innovations resulting in increased portability and shelf life.
• HEPA filter technology accounted for the largest share in 2016, due to the prevalence of respiratory diseases & their transmission coupled with technological advancements in this segment.
• Humidifiers is anticipated to be the fastest growing segment in the forecast period owing to the rising demand for humidifiers in hospitals, schools, home, & healthcare entities, and increased prevalence of airborne infections such as tuberculosis.
• North America therapeutic respiratory devices market is the largest market and is expected to maintain its position over the forecast period owing to the presence of large geriatric population base and rising prevalence of chronic respiratory diseases.
• Major players of the market include, Carefusion Corporation, GE Heathcare, AirSep Corporation, Philips Healthcare, Smiths Medical and Covidien PLC.

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

Healthcare Cloud Computing Market Growth & Trends

The global healthcare cloud computing market size is expected to reach USD 27.8 billion by 2026, according to a new report by Grand View Research, exhibiting a CAGR of 11.8% over the forecast period. The associated benefits of data analytics and increase in demand for flexible & scalable data storage by healthcare professionals is expected to drive the demand for these services over the forecast period.

Healthcare organizations are digitalizing their IT infrastructure and deploying cloud servers to improve features of systems. These solutions help organizations in reducing infrastructure cost & interoperability issues and aid in complying with regulatory standards. Hence, rising demand from health professionals to curb IT infrastructure costs and limit space usage are anticipated to boost market growth over the forecast period.

Increase in government initiatives undertaken to develop and deploy IT systems in this industry is one of the key drivers of this market. Moreover, increase in partnerships between private & public players and presence of a large number of players offering customized solutions are some of the factors anticipated to drive demand in the coming years.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/healthcare-cloud-computing-market

Healthcare Cloud Computing Market Report Highlights

• Non-clinical information systems such as revenue cycle management, health information exchange, financial management, etc., accounted for the largest revenue share in application segment in 2018
• Financial management segment held 23.0% share of the non-clinical segment in 2018 while billing and accounts management is expected to grow at the considerable CAGR during the forecast period
• Private deployment model dominated the overall market owing to its benefits and ease of usage
• Software as a Service (SaaS) model accounted for the largest revenue share as of 2018 as it is widely accepted. This model enables access to applications on a cloud from various devices
• Pay-as-you-go pricing model is anticipated to gain popularity in the coming years, as the consumer only pays for services being used
• North America dominated the market with a share of over 55.0% in 2018. This can be attributed to an increase in demand from payers as well as providers
• Some key players of this healthcare cloud computing market include Athenahealth, Cerner Corporation, CareCloud Corporation, Carestream Corporation, Epic Systems Corporation, Dell Inc., and Sectra AB
• Companies are forming various strategic alliances with clinical research organizations and medical devices companies to further expand their profit margins in the healthcare IT sector. These type of strategic collaborations are expected to aid market growth in the coming years.

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

Dental 3D Printing Market Size, Share, Latest Trends, Industry Growth And Demand

The global dental 3D printing market size is expected to reach USD 9.7 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 29.3% during the forecast period. Rising prevalence of tooth conditions is resulting in increase in tooth replacement surgeries. This, coupled with growing global geriatric population and surging demand for customized dental 3D printing solutions, is providing a significant push to the market. Increasing collaborations by key players and growing awareness among consumers are also likely to help the market gain tremendous traction over the coming years.

Since aged people are more susceptible to oral health issues, rising geriatric population worldwide is translating into upswing in cases of tooth replacement surgeries. As per the findings of the National Institute of Dental and Craniofacial Research, the average teeth remaining of geriatric population (aged 65 years and above) is 18.9. Thus, rise in their population is creating a highly lucrative market for dental 3D printing. Furthermore, innovative and low cost technologies are set to shape the future of the market and increase in usage rate of dental 3D printed products over the forecast period.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/dental-3d-printing-market

Dental 3D Printing Market Report Highlights

• In terms of revenue, the selective laser sintering segment is projected to expand at a CAGR of over 29.0% during the forecast period. This segment will be the leading revenue contributor in the market throughout the forecast horizon owing to the benefits offered such as its chemical resistance, biocompatibility, and excellent surface finishing ability
• In 2025, North America dominated the market with a market share of just over 38.0%. It is expected to witness steady growth over the same period owing to supportive government initiatives and appropriate funding
• Some of the key companies present in the market are SLM Solutions; 3D Systems; ; Roland DG Corporation; Stratasys; Straumann AG GroupDentsPly Sirona Inc.; Prodways Group; Renishaw Inc.; EnvisionTEC; and FormLabs Inc. 

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Everything You Need To Know About Bioinformatics Market

The global bioinformatics market is expected to reach USD 13.47 billion by 2020 growing at an estimated CAGR of 21.2% from 2014 to 2020, according to a new report by Grand View Research, Inc. Growing clinical development of biopharmaceutical and increasing need for three-dimensional drug designing technology are expected to drive the market growth over the next five years.

Furthermore, the development of bioinformatics tools and analysis platforms coupled with the introduction of novel technologies are expected to be high impact rendering factors for the growth of this market. Increasing demand for faster development of novel API and biopharmaceuticals is also expected to enhance the growth of this industry.

Growth in the number of research and development studies in various ‘-omics’ related segments and the need for integration of the large amounts of biological data generated from these studies are also expected to encourage industry players to develop faster, more efficient, and versatile bioinformatics software cum platforms for commercialization.

Bio-content processing accounted for over 47% of the revenue share in 2013. The presence of increasing market demand for genetic database management, and need for related sequence, structural and phylogenic analysis tools and software is the primary factor accounting for this large share.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/bioinformatics-industry

Moreover, the sequence and structural analysis platform segment is expected to grow at the fastest CAGR of over 20% over the forecast period owing to the development of next-generation sequencing and expected reduction in the cost of whole genome exome sequencing. These factors are expected to have a significantly positive impact on the overall growth of this market in the next five years.

Chemo-informatics and genomics accounted for over 50% of revenue share in 2013. Growing demand for novel biomarkers for R&D of biosimilar drugs and biopharmaceuticals is expected to significantly enhance the market penetration over the forecast period.

Proteomic applications are expected to attract a considerable amount of R&D investment in the near future and witness lucrative growth over the forecast period. Developments in three-dimensional drug development technologies are further expected to boost the growth of this segment.

North America accounted for over 40% of the global revenue in 2013. Factors accounting for this large share include the presence of key pharmaceutical companies in the region, which are involved in the clinical development of novel APIs and biosimilar drugs. The presence of a technologically advanced healthcare R&D framework also enhances this region’s investment capabilities for the development of the aforementioned market segments.

Asia Pacific is expected to register the fastest CAGR over the forecast period owing to the presence of companies providing outsourcing services. Furthermore, the presence of high unmet industry needs is expected to be a major factor driving the growth of this region over the forecast period.

Key players in this industry include IBM Life Sciences, BIOVIA, Life Technologies Corporation, Agilent technologies, 3^rd Millennium Inc., Celera Corporation, Affymetrix, BioWisdom Ltd., and Rosetta Biosoftware.

 About Grand View Research       

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

Artificial Intelligence In Drug Discovery Market Growth & Trends

The global artificial intelligence in drug discovery market size is expected to reach USD 3.5 billion by 2027, expanding at a CAGR of 28.8%, according to a new report by Grand View Research, Inc. The growing adoption of artificial intelligence (AI) platforms aimed at reducing the overall cost associated with drug discovery and to enhance results is expected to propel the demand for these platforms in the pharma market.

Based on the application, the drug optimization and repurposing segment accounted for the largest revenue share in 2019. AI platforms help in identifying alternative applications for existing medicines. This can help pharma companies diversify their portfolio of offerings and assist in producing alternative therapies through minor alterations in the pharmaceutical product. Furthermore, AI platforms also enable researchers to identify the toxic effects of the medicine on the body and thus reduce the chances of adverse effects.

In 2019, oncology application accounted for the largest share whereas, the infectious disease application segment is expected to emerge as the fastest-growing application segment over the forecast period. Artificial intelligence already plays a vital role in the early detection of cancer. Furthermore, as treatments for cancer may vary for each patient, personalized medicine has proven to be an effective alternative.

North America dominated the market with a revenue share of 59.4% in 2019 owing to the increasing adoption of artificial intelligence and the presence of a large number of market players. Asia Pacific is expected to emerge as the fastest-growing region in the market over the forecast period. The growing adoption of new technology in India and China for new drug development and a focus towards boosting pharmaceutical capacities within the countries is expected to drive the market in the region.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/artificial-intelligence-drug-discovery-market

Artificial Intelligence In Drug Discovery Market Report Highlights

• The drug optimization and repurposing segment accounted for the largest revenue share of 54.4% in 2019
• By therapeutic area, the oncology segment was valued at USD 125.0 million in 2019
• By therapeutic area, the infectious disease segment is expected to witness the fastest growth of 31.4% from 2020 to 2027
• In Asia Pacific, the AI in drug discovery market is expected to witness a CAGR of 32.1% from 2020 to 2027
• North America and Europe together accounted for 78.6% share of the market revenue in 2019.

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

Facial Fat Transfer Market Worth $4.2 Billion By 2026

The global facial fat transfer market size is anticipated to reach USD 4.2 billion by 2026 at a CAGR of 10.7%, according to a new report by Grand View Research, Inc. The growth of the market is attributed to various benefits of fat grafting and the growing geriatric population. Furthermore, technological advancements in aesthetic devices are also anticipated to fuel market growth.

According to the United Nations data, individuals above the age of 65 years are accounted for nearly 9% in 2019, while the number is estimated to reach nearly 11% by 2050. In addition, the number of individuals aged above 80 years is 143 million in 2019 and is expected to reach 426 million in 2050. The facial skin of aging people is prone to deep wrinkles, dry skin, volume loss and elasticity loss, thereby driving the facial fat transfer market growth.

Furthermore, the increasing usage of social media, beauty apps, and the extensive marketing techniques of skincare and aesthetic device companies have led to increase in obsession with flawless skin and desire to look perfect. For instance, BeautyPlus Me-Perfect Camera, a photo editing app, became the top trending Google Play store app in 2016, thus highlighting the rise in desire to look flawless in order to receive social media appreciation in the form of ‘likes’.

The market is charactetized by few established players and several start-ups or small enterprises. This can be attributed to the presence of ambiquous regulatory scenairo and capital intensive product development process. Furthermore, the clinicians and plastic surgeons performing these procedures also limited in number and have high fees, thus signifcantly affecting the adoption of this technique.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/facial-fat-transfer-market

Facial Fat Transfer Market Report Highlights

• The current demand for facelifts and other facial aesthetic cosmetic procedures is mainly due to individual’s dissatisfaction with their appearance and a strong desire for a youthful appearance
• Fat transfer procedures with abdomen as donor site dominated the market share in 2018. This can be attributed to high adipocyte viability of fat obtained from this region
• North America dominated the market in 2018. This can be attributed to the availability and adoption of advanced treatment options in this region
• The Asia Pacific is anticipated to witness a lucrative growth over the forecast period. This can be attributed to the increasing disposable income and increasing awareness regarding the various aesthetic procedures
• Some of key companies profiled are Ranfac Corp; Cytori Therapeutics, Inc.; Allergan Plc.; Medikan International Inc.; and Stanford Health Care.

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/air-mattress-market/request/rs1

 

Inhalable Drugs Market Size Worth $40.6 Billion By 2026

The global inhalable drugs market size is expected to reach over USD 40.6 billion by 2026, according to a new report by Grand View Research, Inc., registering a CAGR of 6.3% over the forecast period. Rising prevalence of respiratory diseases and increasing geriatric population are some of the key factors expected to drive the market. Chronic obstructive pulmonary disease (COPD) is a life-threatening respiratory ailments, which is projected to become the third leading cause of death globally. This will increase the demand for inhalable drugs.

According to the Global Burden of Disease study, in 2016, 251 million cases of COPD were reported worldwide. Hence, the need for developing new inhalable drugs has increased. For instance, in January 2019, Verona Pharma received WHO approval for developing Ensifentrine indicated for COPD, which has completed Phase II of clinical trials.

Advancements in inhalable drugs is anticipated to propel the inhalable drugsmarket. Nanoparticles are studied for the development of advanced inhalation drugs. For instance, in April 2019, a scientist from Queensland University of Technology conducted a research using chitosan nanoparticles loaded with inhalation powder for lung cancer. These nanoparticles can easily penetrate the lower respiratory tract and can diffuse into the bloodstream.

Rising prevalence of non-respiratory diseases such as diabetes and Parkinson’s diseases is also expected to drive the market. Therefore, manufacturers are developing cost-effective and innovative inhalable drugs. For instance, in January 2019, MannKind Corporation developed and commercialized Afrezza for diabetic patients.

Presence of strong pipeline drugs is considered to be one of the major factors estimated to boost the market growth. There are more than 220 ongoing projects under clinical trials globally. For instance, GlaxoSmithKline’s triple combination therapy of Fluticasone Furoate/Vilanterol/Umeclidinium Bromide to treat asthma is in Phase III and is likely to be launched during the forecast period.

Companies are undergoing strategic initiatives such as collaborations, mergers and acquisitions, partnerships, and awareness programs to widen their product portfolio and gain a stronger foothold in the market. For instance, in July 2019, Cipla, Inc. entered into a joint venture with Shanghai-based Jiangsu Acebright Pharmaceuticals to establish a company in the People’s Republic of China to manufacture respiratory products.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/inhalable-drugs-market

Further key findings from the study suggest:

• By product, the dry powder formulation segment dominated the market for inhalable drugs in 2018 owing to benefits such as low density and ability to disperse easily through inhalers
• Based on application, respiratory diseases held the largest market share in terms of revenue in 2018, due to high prevalence of asthma and COPD. The non-respiratory diseases segment is growing at a rapid pace owing to the high opportunity in management of various neurological disorders
• North America held the leading position in the global inhalable drugsmarket for inhalable drugs in 2018, driven by established pharmaceutical industry and healthcare facilities and growing awareness about the use of inhalers. The Asia Pacific market is projected to exhibit the fastest growth during the forecast period.
• Key players in this industry include AstraZeneca; Vectura, Cipla Inc.; GlaxoSmithKline; Novartis; Mundipharma; Boehringer Ingelheim International GmbH; and Mylan.

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/inhalable-drugs-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Hybrid Imaging Market Size, Share, Latest Trends, Industry Growth And Demand By 2026

The global hybrid imaging market size is expected to reach USD 9.8 billion by 2026, according to a new report by Grand View Research, Inc., registering a 4.5% CAGR over the forecast period. Increasing demand for accurate diagnostic techniques for cancer and cardiac disorders is expected to drive the market. Rising government initiatives for creating awareness regarding multimodal imaging devices are also expected to contribute toward market growth.

Increasing installation of such devices in research centers and institutions to enhance diagnostics in the field of oncology, cardiology, neurology, and others is expected to boost market growth. Leading players in the market are showcasing various multimodal imaging devices at medical conferences to increase their product reach. However, high cost and complications associated with these devices is expected to impede market growth during the forecast period.

Hybrid imaging devices require skilled professionals to understand the data collected by these combined devices. Therefore, various training programmes are conducted by several non-profit and government funded organizations to increase the adoption of hybrid imaging devices for the diagnosis of a disease.

North America dominated the hybrid/multimodal imaging market in 2018 and is expected to grow at a significant rate during the forecast period. The growth observed in this region is largely due to presence of global players and increasing adoption of advanced equipment such as hybrid imaging devices. Moreover, increasing awareness regarding nuclear medicine and molecular diagnostics in the region is expected to contribute toward the growth in this region.

Asia Pacific is expected register the strongest growth over the forecast period. This can be primarily attributed to growing usage of advanced devices such as PET/CT systems in radiology departments across emerging economies. Thriving medical tourism in numerous countries has piqued the interest of global market players, who are looking to invest in the development and launch of advanced software in the region. The Europe market is fueled by ongoing efforts by various non-profit organizations in conducting educational and training programs for scientists, physicians, technologists, physicists, radiographers, and others in the field.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/hybrid-imaging-market

Further key findings from the report suggest:

• PET/CT systems held the largest share in 2018 based on type, and the segment is expected to grow at a significant pace due to increasing development and installation of these devices in various end users such as hospitals and diagnostic centers
• SPET/CT systems segment in hybrid imaging market will exhibit the fastest growth rate during the forecast period. Data captured by SPET/CT helps in understanding the detailed morphology and pathogenesis of a disease, thereby enhancing the quality of diagnostic output
• In 2018, the oncology segment held the dominant share of hybrid imaging systems market by application, largely due to increasing number of cancer cases and growing awareness for cancer diagnosis
• The cardiology segment is expected to grow at the fastest pace during the forecast period. Cardiac hybrid imaging helps in accurately capturing morphological and functional information in a single setting, thereby easing the diagnosis of cardiac disorders
• Hospitals held the largest market share in 2018 on the basis of end use, mainly due to higher installation of technologically advanced devices for early diagnosis and treatment of a disease
• Geographically, Asia Pacific is expected to register the fastest growth rate during the forecast period due to increasing number of radiology departments in the region and launch of advanced software by leading players.

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/hybrid-imaging-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Cranial Clamps Market Insights, New Innovations, Research And Growth Factor till 2026

The global cranial clamps market is anticipated to reach USD 319.30 million by 2026, registering a CAGR of 4.7% during the forecast period, according to a new report by Grand View Research, Inc. increasing incidence of road accidents along with the prevalence of brain tumors and Traumatic Brain Injuries (TBIs) is anticipated to boost the market growth.

As per the National Health Portal, India, the incidence of central nervous system (CNS) tumors is 5 to 10 per 100,000 population. According to the Centers for Disease Prevention and Control (CDC), in 2014, about 2.87 million TBI related Emergency Department Visits, Hospitalizations and Deaths (EDHD) in U.S.

Cranial clamps are used during c; otolaryngology or ear, throat, and nose procedures; and orthopedics or musculoskeletal system related surgeries for providing the rigid fixation to the neck and head. Cranial clamps enables patient immobilization and reduces the risk of soft tissue injuries during the micro procedures. Increasing prevalence of brain and CNS tumors and TBIs is expected to drive the growth of the cranial clamps market over the forecast period.

Increasing initiatives by the government and non-profitable organizations for spreading awareness and the treatment of neurological diseases are also projected to fuel the market growth. For instance, new model of care for neurological services was launched in Ireland by the director-general of Health Service Executive (HSE).

For more info visit here: https://www.grandviewresearch.com/industry-analysis/cranial-clamps-market

Further key findings from the study suggest:

• Surgery segment dominated the cranial clamps market by application in 2018 owing to the usage as the first line of treatment for brain tumors coupled with increasing prevalence of CNS tumors
• Adult patient formed the largest segment in 2018, owing to increasing prevalence of spinal tumors and TBI
• Hospitals end user segment held the leading market share in 2018, owing to increasing number of neurosurgeries and rise in TBI-related emergency visits
• North America led the global cranial clamps market in 2018, owing to the increasing incidence of neurological disorders such as Idiopathic intracranial hypertension (IIH) along with the presence of favorable government policies
• Few of the key market players are Pro-med instruments GmbH, Integra LifeSciences Corporation, Allen Medical (Hill-rom), B. Braun, Micromar Ind e com, and Eschmann Holdings Ltd (Steris PLC)

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/cranial-clamps-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com

 

Compound Management Market Booming Worldwide Opportunity, Upcoming Trends and Demand, Growth Forecast To 2026

The global compound management market size is expected to reach USD 885.9 million by the end of 2026, expanding at a CAGR of 16.7%, according to a new report by Grand View Research, Inc. Growing biopharmaceutical industry and bio banking sector is fueling the market growth.The growth of translational research and personalized medicine is driving the market.

Efficient compound management is tremendously important for the success of drug discovery, where traceability, reliability, speed, and throughput are fundamental. Maintaining samples at the precise temperature, under nitrogen or dry air to prevent fluctuations of stock concentrations, and in a dark environment in order to avoid photo degradation, can help ensure consistency and longevity of samples.

Compounds of a high integrity lead to reliable results while locating drug candidates. Moreover, the collection, storage, and distribution of human biological samples supports the development of the R&D industry. In addition, it aids to understand the mechanisms of diseases as well as support the trend to provide personalized medicines.

Automated storage systems eliminate or reduce the risks and provide reliable and correct environmental conditions to protect samples from precipitation or degradation. A management system like Verso tracks sample data, including location and type, enables quick and easy finding of the sample. The fully automated systems improve the process of drug discovery by eliminating error-prone and time-consuming tasks.

North America dominated the market in 2018 owing to strong base of biotechnology and pharmaceutical companies in the region. These companies are involved in drug discovery activities, which, in turn, led to the growth of the market in the region. The Asia Pacific market is anticipated to grow fast over the forecast period. This is attributed to ongoing studies in private-public collaborations, drug discovery, and government initiatives in the region.

For more info visit here: https://www.grandviewresearch.com/industry-analysis/compound-management-market

Compound Management Market Report Highlights

• The automated compound/sample storage systems segment was the largest in 2018 accounting for 45.2% of the market share. This is attributed to the fact that it eliminates or reduces error and saves time
• On the basis of sample type, chemical compounds dominated the market in 2018 with a largest share of 53.0% due to the increasing drug discovery activities, resulting in an increased demand for compounds and positively affecting thecompound management market growth
• The bio banking segment is anticipated to exhibit the fastest CAGR of 17.1% over the forecast period. There has been increase in the number of organizations involved in the collection and storage of human biomaterials in line with the increasing use of human biomaterials in research as a replacement to animal models. It is anticipated to support the market growth
• North America led the market owing to the presence of large biopharmaceutical companies engaged in drug discovery and require huge maintenance of chemical libraries. Thus, to maintain the productivity of such biologics and drugs, most of the leading biopharma and pharma companies have started building storage facilities
• Some of the players operating in the market are Tecan, Roche, Brooks Life Sciences, Evotec, Hamiltons, BioAscent, Titian Software Limited, AXXAM S.p.A., TTP Labtech, TCG Lifesciences Private Limited, WuXi AppTec, and HDC GmbH.

Request a Sample Copy @ https://www.grandviewresearch.com/industry-analysis/compound-management-market/request/rs1

About Grand View Research        

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more info visit @ https://www.grandviewresearch.com